JP4495349B2 - 癌の遺伝マーカーを生物学的サンプルにおいて検出するための核酸配列 - Google Patents

癌の遺伝マーカーを生物学的サンプルにおいて検出するための核酸配列 Download PDF

Info

Publication number
JP4495349B2
JP4495349B2 JP2000596180A JP2000596180A JP4495349B2 JP 4495349 B2 JP4495349 B2 JP 4495349B2 JP 2000596180 A JP2000596180 A JP 2000596180A JP 2000596180 A JP2000596180 A JP 2000596180A JP 4495349 B2 JP4495349 B2 JP 4495349B2
Authority
JP
Japan
Prior art keywords
seq
sequence
psa
nucleic acid
oligonucleotide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2000596180A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002535014A5 (enExample
JP2002535014A (ja
Inventor
ハービー，リチャード・シー
クラーク，トーマス・ジェイ，ジュニア
Original Assignee
ジェン−プローブ・インコーポレーテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ジェン−プローブ・インコーポレーテッド filed Critical ジェン−プローブ・インコーポレーテッド
Publication of JP2002535014A publication Critical patent/JP2002535014A/ja
Publication of JP2002535014A5 publication Critical patent/JP2002535014A5/ja
Application granted granted Critical
Publication of JP4495349B2 publication Critical patent/JP4495349B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2000596180A 1999-01-28 2000-01-28 癌の遺伝マーカーを生物学的サンプルにおいて検出するための核酸配列 Expired - Fee Related JP4495349B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11764099P 1999-01-28 1999-01-28
US60/117,640 1999-01-28
PCT/US2000/002270 WO2000044940A2 (en) 1999-01-28 2000-01-28 Nucleic acid sequences for detecting genetic markers for cancer in a biological sample

Publications (3)

Publication Number Publication Date
JP2002535014A JP2002535014A (ja) 2002-10-22
JP2002535014A5 JP2002535014A5 (enExample) 2007-03-15
JP4495349B2 true JP4495349B2 (ja) 2010-07-07

Family

ID=22374015

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000596180A Expired - Fee Related JP4495349B2 (ja) 1999-01-28 2000-01-28 癌の遺伝マーカーを生物学的サンプルにおいて検出するための核酸配列

Country Status (6)

Country Link
US (5) US6551778B1 (enExample)
EP (1) EP1151142A2 (enExample)
JP (1) JP4495349B2 (enExample)
AU (1) AU767587B2 (enExample)
CA (1) CA2360073C (enExample)
WO (1) WO2000044940A2 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2324503T3 (es) 1997-04-10 2009-08-07 Stichting Katholieke Universiteit University Medical Centre Nijmegen Pca3, genes pca3 y metodos de uso.
EP1151142A2 (en) * 1999-01-28 2001-11-07 Gen-Probe Incorporated Nucleic acid sequences for detecting genetic markers for cancer in a biological sample
JP2003510075A (ja) * 1999-09-29 2003-03-18 ディグノキュアー・インコーポレーテッド 良性および悪性の前立腺組織におけるｐｃａ３メッセンジャーｒｎａ種
AU2002217991A1 (en) * 2000-11-21 2002-06-03 Diadexus, Inc. Compositions and methods relating to prostate specific genes and proteins
WO2003068918A2 (en) * 2002-02-11 2003-08-21 Auburn University High-sensitivity real-time polymerase chain reaction for detection of nucleic acids
JP4824540B2 (ja) 2003-02-07 2011-11-30 ダイアノキュアー インク． サンプル中の前立腺癌を検出する方法
ES2321131T3 (es) * 2003-05-01 2009-06-02 Veridex Llc Ensayo intraoperativo de ganglios linfaticos.
CA2491067A1 (en) 2004-12-24 2006-06-24 Stichting Katholieke Universiteit Mrna rations in urinary sediments and/or urine as a prognostic marker for prostate cancer
US20070130694A1 (en) * 2005-12-12 2007-06-14 Michaels Emily W Textile surface modification composition
WO2008080029A2 (en) 2006-12-21 2008-07-03 Gen-Probe Incorporated Methods and compositions for nucleic acid amplification
US20110091883A1 (en) * 2009-02-18 2011-04-21 Helicos Biosciences Corporation Methods for analyzing minute cellular nucleic acids
CN102414554B (zh) * 2009-04-22 2014-11-26 威斯康星校友研究基金会 采用液晶的分析物检测
EP2449132B1 (en) 2009-07-01 2015-05-13 Gen-Probe Incorporated Methods and compositions for nucleic acid amplification
MX338883B (es) * 2010-07-27 2016-05-04 Genomic Health Inc Metodo para usar expresion de gen para determinar el pronostico de cancer de prostata.
EP2616555B1 (en) 2010-09-16 2017-11-08 Gen-Probe Incorporated Capture probes immobilizable via l-nucleotide tail
US9255293B2 (en) 2010-11-01 2016-02-09 Gen-Probe Incorporated Integrated capture and amplification of target nucleic acid for sequencing
EP2809807B1 (en) 2012-02-01 2019-04-10 Gen-Probe Incorporated Asymmetric hairpin target capture oligomers
EP3312749B1 (en) 2012-03-05 2024-05-01 OY Arctic Partners AB Methods and apparatuses for predicting risk of prostate cancer and prostate gland volume
US12326453B2 (en) 2014-03-28 2025-06-10 Opko Diagnostics, Llc Compositions and methods for active surveillance of prostate cancer
FI3123381T3 (fi) 2014-03-28 2023-11-27 Opko Diagnostics Llc Eturauhassyövän diagnosointiin liittyviä koostumuksia ja menetelmiä
CA2979559A1 (en) 2015-03-27 2016-10-06 Opko Diagnostics, Llc Prostate antigen standards and uses thereof
EP3448998B1 (en) * 2016-04-27 2020-06-03 Gen-Probe Incorporated Blood cell lysis reagent
CN111518170A (zh) * 2020-05-09 2020-08-11 新乡医学院 基于fret的psa荧光探针、制备方法及其应用
CA3254118A1 (en) 2022-03-15 2023-09-21 Diagenode S A DETECTION OF THE METHYLATION STATE OF A DNA SAMPLE

Family Cites Families (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3725010A (en) * 1971-08-23 1973-04-03 Beckman Instruments Inc Apparatus for automatically performing chemical processes
US5283174A (en) 1987-09-21 1994-02-01 Gen-Probe, Incorporated Homogenous protection assay
CA2020958C (en) 1989-07-11 2005-01-11 Daniel L. Kacian Nucleic acid sequence amplification methods
US5851764A (en) * 1990-10-25 1998-12-22 The Trustees Of Columbia University In The City Of New York Human prostate tumor inducing gene-1 and uses thereof
AU662906B2 (en) 1991-06-26 1995-09-21 F. Hoffmann-La Roche Ag Methods for detection of carcinoma metastases by nucleic acid amplification
CA2135073C (en) 1992-05-06 2002-11-19 Daniel L. Kacian Nucleic acid sequence amplification method, composition and kit
US5786148A (en) 1996-11-05 1998-07-28 Incyte Pharmaceuticals, Inc. Polynucleotides encoding a novel prostate-specific kallikrein
WO1994010343A1 (en) 1992-10-29 1994-05-11 Thomas Jefferson University Methods of detecting micrometastasis of prostate cancer
US5674682A (en) * 1992-10-29 1997-10-07 Thomas Jefferson University Nucleic acid primers for detecting micrometastasis of prostate cancer
EP1757694A3 (en) 1992-11-05 2008-02-27 Sloan Kettering Institute For Cancer Research Prostate-specific membrane antigen
US5516639A (en) 1993-07-22 1996-05-14 Mayo Foundation For Medical Education And Research Antibodies specific for human prostate glandular kallkrein
US6103237A (en) * 1993-07-22 2000-08-15 Hybritech Incorporated Stable variant hK2 polypeptide
US6569432B1 (en) * 1995-02-24 2003-05-27 Sloan-Kettering Institute For Cancer Research Prostate-specific membrane antigen and uses thereof
FR2714062B1 (fr) * 1993-12-22 1996-02-16 Bio Merieux Promoteur modifié pour ARN polymérase, sa préparation et ses applications.
US5599677A (en) 1993-12-29 1997-02-04 Abbott Laboratories Immunoassays for prostate specific antigen
EP0760006A1 (en) 1994-04-15 1997-03-05 The Trustees Of Columbia University In The City Of New York Method for molecular staging of prostate cancer
JPH10500294A (ja) 1994-05-10 1998-01-13 マヨ ファウンデーション フォー メディカル エデュケーション アンド リサーチ 組換え型ｈｋ２ポリペプチド
AU4897896A (en) * 1995-01-04 1996-07-24 Trustees Of Boston University Primers for the pcr amplification of metastatic sequences
US5698402A (en) 1995-02-23 1997-12-16 Dianon Systems, Inc. Methods for diagnosing benign prostatic hyperplasia
US7037647B1 (en) * 1995-02-24 2006-05-02 Sloan-Kettering Institute For Cancer Research Prostate-specific membrane antigen and uses thereof
US5773292A (en) 1995-06-05 1998-06-30 Cornell University Antibodies binding portions, and probes recognizing an antigen of prostate epithelial cells but not antigens circulating in the blood
GB2302874B (en) * 1995-06-29 1999-11-10 Orion Yhtymae Oy Novel proteins
WO1997007242A1 (en) 1995-08-16 1997-02-27 Steven Lehrer Method for detecting circulating breast cancer cells
US5710007A (en) 1995-09-29 1998-01-20 Luderer; Albert A. Methods for diagnosing prostatic adenocarcinoma
US5861248A (en) 1996-03-29 1999-01-19 Urocor, Inc. Biomarkers for detection of prostate cancer
EP0891550A1 (en) 1996-04-05 1999-01-20 The Johns Hopkins University School Of Medicine A method of enriching rare cells
AU2676197A (en) 1996-04-16 1997-11-07 Smithkline Beecham Corporation A method for detection of prostate specific antigen used in monitoring and diagnosis of prostate cancer
US5858673A (en) * 1996-06-24 1999-01-12 Charlotte-Mecklenburg Hospital Authority Method for detecting prostate cells
US6117635A (en) * 1996-07-16 2000-09-12 Intergen Company Nucleic acid amplification oligonucleotides with molecular energy transfer labels and methods based thereon
WO1998021365A2 (en) 1996-11-14 1998-05-22 Mayo Foundation For Medical Education And Research Method for detection of metastatic prostate cancer
US6479263B1 (en) 1996-11-14 2002-11-12 Baylor College Of Medicine Method for detection of micrometastatic prostate cancer
CA2218754A1 (en) 1996-11-15 1998-05-15 Eli Lilly And Company Recombinant psa expression vectors and assays using the same
US6100444A (en) 1997-02-11 2000-08-08 University Of Rochester Medical Center Prostate specific regulatory nucleic acid sequences and transgenic non-human animals expressing prostate specific antigen
US6630305B1 (en) 1999-11-12 2003-10-07 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US7033827B2 (en) * 1997-02-25 2006-04-25 Corixa Corporation Prostate-specific polynucleotide compositions
US6759515B1 (en) 1997-02-25 2004-07-06 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US6620922B1 (en) 1997-02-25 2003-09-16 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
WO1998040513A1 (en) 1997-03-11 1998-09-17 Ferrari Anna C Method of detecting prostate cancer metastasis
WO1998046788A2 (en) * 1997-04-11 1998-10-22 Micromet Gesellschaft Für Biomedizinische Forschung Mbh Primers and methods for the detection of disseminated tumor cells
ES2312186T3 (es) 1997-04-30 2009-02-16 Hybritech Incorporated Formas del antigeno prostatico especifico y procedimientos para su deteccion.
AU8259798A (en) * 1997-06-20 1999-01-04 George G Klee Method for detection of breast cancer
US5817798A (en) * 1997-09-17 1998-10-06 Abbott Laboratories Rapid RNA isolation procedure in the presence of a transition metal ion
US20030215803A1 (en) * 2000-12-07 2003-11-20 Garcia Pablo Dominguez Human genes and gene expression products isolated from human prostate
US8101349B2 (en) * 1997-12-23 2012-01-24 Novartis Vaccines And Diagnostics, Inc. Gene products differentially expressed in cancerous cells and their methods of use II
JP2000069969A (ja) 1998-08-28 2000-03-07 Hitachi Chem Co Ltd プライマーＤＮＡ及びこれを用いる前立腺特異抗原をコードするｍＲＮＡの検出方法
EP1151142A2 (en) * 1999-01-28 2001-11-07 Gen-Probe Incorporated Nucleic acid sequences for detecting genetic markers for cancer in a biological sample
WO2000049158A2 (en) * 1999-02-18 2000-08-24 Compugen Ltd. Psa and klk-2 splicing variants
CA2362885A1 (en) 1999-03-11 2000-09-14 Mount Sinai Hospital Human kallikrein-like genes
WO2000065067A2 (en) 1999-04-23 2000-11-02 University Of Washington Prostate-specific polynucleotides, polypeptides and their methods of use
AU5416700A (en) 1999-05-20 2000-12-12 Fahri Saatcioglu Differentially expressed genes in prostate cancer
WO2001060860A2 (en) * 2000-02-17 2001-08-23 Millennium Predictive Medicine, Inc. Genes differentially expressed in human prostate cancer and their use
EP2253717B1 (en) 2000-04-07 2014-04-30 Eiken Kagaku Kabushiki Kaisha Method of amplifying nucleic acid by using double-stranded nucleic acid as template
US20020132976A1 (en) 2000-04-10 2002-09-19 Artur Pedyczak Immunogenic peptides derived from prostate-specific antigen (PSA) and uses thereof
ATE325871T1 (de) 2000-05-01 2006-06-15 Eiken Chemical Verfahren zur erkennung des produkts einer nukleinsäuresynthetisierungsreaktion
CN1283807C (zh) * 2001-06-18 2006-11-08 荣研化学株式会社 有效检测双链核酸的方法
US20050112705A1 (en) * 2002-03-14 2005-05-26 Laurent Bracco Variants of human kallikrein-2 and kallikrein-3 and uses thereof
US7348142B2 (en) * 2002-03-29 2008-03-25 Veridex, Lcc Cancer diagnostic panel
JP4824540B2 (ja) 2003-02-07 2011-11-30 ダイアノキュアー インク． サンプル中の前立腺癌を検出する方法
US20040223885A1 (en) * 2003-05-06 2004-11-11 Keen Randy E. Apparatus for the automated synthesis of polynucleotides
US20060008468A1 (en) * 2004-06-17 2006-01-12 Chih-Sheng Chiang Combinations of tumor-associated antigens in diagnostics for various types of cancers

Also Published As

Publication number Publication date
US20090035773A1 (en) 2009-02-05
US20080026398A1 (en) 2008-01-31
CA2360073A1 (en) 2000-08-03
WO2000044940A3 (en) 2000-12-07
JP2002535014A (ja) 2002-10-22
US20030104448A1 (en) 2003-06-05
WO2000044940A2 (en) 2000-08-03
US7267956B2 (en) 2007-09-11
US6551778B1 (en) 2003-04-22
CA2360073C (en) 2011-01-18
AU767587B2 (en) 2003-11-20
EP1151142A2 (en) 2001-11-07
US20050118630A1 (en) 2005-06-02
US6811985B2 (en) 2004-11-02
AU3475500A (en) 2000-08-18

Similar Documents

Publication Publication Date Title
JP4495349B2 (ja) 癌の遺伝マーカーを生物学的サンプルにおいて検出するための核酸配列
US11104958B2 (en) Method to detect prostate cancer in a sample
JP4944041B2 (ja) 前立腺癌の予後判定用マーカー及び／又はテラノスティックマーカーとなる、尿沈渣及び／又は尿のｍＲＮＡ比
US20090226925A1 (en) Methods for Detecting Circulating Tumor Cells
EP0760006A1 (en) Method for molecular staging of prostate cancer
CA2432365A1 (en) Specific method of prostate cancer detection based on pca3, and kits therefore
US12410424B2 (en) Diagnosis of prostate cancer
JP4315812B2 (ja) 癌腫の分子診断および予後

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060912

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070124

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090708

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20090713

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20090713

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20090714

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090928

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20091026

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100215

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20100305

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20100402

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20100409

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130416

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130416

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140416

Year of fee payment: 4

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees